Not recruiting
Registered drug
Study on the Effects of Pseudoephedrine on Cycling Performance in Healthy Volunteers
Registered drug
Countries:
Belgium
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:Lactose Monohydrate
Find therapies in clinical trials near you – page 101
- recruiting
- 3 987
- countries
- 28
- conditions
- 2 109
3 987 trials recruiting28 European countries2 109 conditions coveredUpdated today
2 187 trials match your criteria
Not recruiting
Bladder transitional cell carcinoma
Not recruitingStudy on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment
Registered drug
Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment
Registered drug
- Disease:Bladder transitional cell carcinoma
- Substances:DurvalumabInfliximab+1
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Durvalumab
Not recruiting
Coronavirus infection
Not recruitingStudy on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems
Registered drug
Study on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems
Registered drug
- Disease:Coronavirus infection
- Substances:CilgavimabSipavibart+1
Countries:Belgium
Belgium- Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
- Substances:Cilgavimab
Not recruiting
Colitis ulcerative
Not recruitingStudy on How Etrasimod Arginine is Absorbed in Blood and Breast Milk of Healthy Breastfeeding Women with Ulcerative Colitis and Other Inflammatory Disorders
InvestigationalNo placebo
Study on How Etrasimod Arginine is Absorbed in Blood and Breast Milk of Healthy Breastfeeding Women with Ulcerative Colitis and Other Inflammatory Disorders
InvestigationalNo placebo
- Disease:Colitis ulcerative
- Substances:Etrasimod Arginine
Countries:Belgium
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:Etrasimod Arginine
Not recruiting
Registered drugNo placebo
Study on the Immune Response and Safety of RSVPreF3 OA Vaccine Alone and with COVID-19 mRNA Vaccine in Adults Aged 50 and Above
Registered drugNo placebo
- Substances:RaxtozinameranRespiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Raxtozinameran
Not recruiting
Pneumococcal immunisation
Not recruitingStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
Registered drugNo placebo
Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
Registered drugNo placebo
- Disease:Pneumococcal immunisation
- Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197Pneumococcal polysaccharide serotype 1+29
Countries:Belgium
Belgium- Participants:0–17 years · Healthy volunteers
- Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197
Not recruiting
Papilloma viral infection
Not recruitingStudy on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45
Registered drug
Study on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45
Registered drug
- Disease:Papilloma viral infection
- Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By RdnaHuman Papillomavirus Type 16 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna+7
Countries:Belgium
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
Not recruiting
Cardiac amyloidosis+2
Not recruitingStudy on How Tafamidis is Absorbed in the Blood of Healthy Adults with Transthyretin Amyloid Cardiomyopathy
InvestigationalNo placebo
Study on How Tafamidis is Absorbed in the Blood of Healthy Adults with Transthyretin Amyloid Cardiomyopathy
InvestigationalNo placebo
- Disease:Cardiac amyloidosisAmyloidosis+1
- Substances:Tafamidis
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Tafamidis
Not recruiting
Rabies
Not recruitingStudy Comparing Intradermal and Intramuscular Rabies Vaccine Doses in Adults
Registered drugNo placebo
Study Comparing Intradermal and Intramuscular Rabies Vaccine Doses in Adults
Registered drugNo placebo
- Disease:Rabies
- Substances:Rabies virus (inactivated) strain Flury LEP
Countries:Belgium
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:Rabies virus (inactivated) strain Flury LEP
Not recruiting
COVID-19
Not recruitingStudy on the Immune Response of COVID-19 Vaccine Tozinameran with Flu Vaccine Combinations in Adults Aged 65 and Over
Registered drug
Study on the Immune Response of COVID-19 Vaccine Tozinameran with Flu Vaccine Combinations in Adults Aged 65 and Over
Registered drug
- Disease:COVID-19
- Substances:TozinameranA/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)+6
Countries:Belgium
Belgium- Participants:65+ years · Healthy volunteers
- Substances:Tozinameran
Not recruiting
Spinal muscular atrophy
Not recruitingStudy on the Safety and Tolerability of BIIB115 for Children with Spinal Muscular Atrophy Previously Treated with Gene Therapy
Investigational
Study on the Safety and Tolerability of BIIB115 for Children with Spinal Muscular Atrophy Previously Treated with Gene Therapy
Investigational
- Disease:Spinal muscular atrophy
- Substances:BIIB115
Countries:Belgium
Belgium- Participants:0–17 years · 18–64 years · Healthy volunteers
- Substances:BIIB115
Not recruiting
Pneumonia chlamydial+2
Not recruitingStudy on the Effects of Doxycycline for Preventing Antibiotic Resistance in Patients with Bacterial STDs (Chlamydia, Gonorrhea, Syphilis)
Registered drugNo placebo
Study on the Effects of Doxycycline for Preventing Antibiotic Resistance in Patients with Bacterial STDs (Chlamydia, Gonorrhea, Syphilis)
Registered drugNo placebo
- Disease:Pneumonia chlamydialSyphilis+1
- Substances:Doxycycline Monohydrate
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Doxycycline Monohydrate